Significance of p53 protein expression in growth pattern of esophageal squamous cell carcinoma

Oncology Reports

Volumn 5, Issue 5, 1998, Pages 1119-1123

  Nozoe, Tadahiro ^a   Kuwano, Hiroyuki ^a   Toh, Yasushi ^a   Watanabe, Masayuki ^a   Kitamura, Masayuki ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Esophageal carcinoma; Growth pattern; Intraepithelial carcinoma; P53 expression

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER GROWTH; CARCINOMA IN SITU; ESOPHAGUS CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0031854562     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.5.1119     Document Type: Article

References (24)

1. Kuwano H, Matsuda H, Matsuoka H, Kai H, Okudaira Y and Sugimachi K: Intra-epithelial carcinoma concomitant with esophageal squamous cell carcinoma. Cancer 59: 783-787, 1987.
2. Kuwano H, Nagamatsu M, Ohno S, Matsuda H, Mori M and Sugimachi K: Coexistence of intraepithelial carcinoma and grandular differentiation in esophageal squamous cell carcinoma. Cancer 62: 1568-1572, 1988.
3. Mandard AM, Toumeux J, Jignoux M, Blanc L, Segol P and Mandard JC: In situ carcinoma of the esophagus: macroscopic study with particular reference to the Lugol test. Endoscopy 12: 51-57, 1980.
4. Soga J, Tanaka O, Sasaki K, Kawaguchi M and Muto T: Superficial spreading carcinoma of the esophagus. Cancer 50: 1641-1645, 1982.
5. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC and Vogelstein B: Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708, 1989.
6. Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991.
7. Casson AG, Mukhopadhyay T, Cleary KR, Ro JY, Levin B and Roth JA: p53 gene mutations in Barrett's epithelium and esophageal cancer. Cancer Res 51: 4495-4499, 1991.
8. Bennett WP, Hollstein MC, Metcalf RA, Welsh JA, He A, Zhu SM, Kusters I, Resau JH, Trump BF, Lane DP and Harris CC: p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res 52: 6092-6097, 1992.
9. Dolcetti R, Doglioni C, Maestro R, Gasparotto D, Barzan L, Pastore A, Romanelli M and Boiocchi M: p53 over expression is an early event in the development of human squamous cell carcinoma of the larynx-genetic and prognostic implictions. Int J Cancer 52: 178-182, 1992.
10. Chung KY, Mukhopadhyay T, Kim J, Casson A, Ro JY, Geopfert H, Hong WK and Roth JA: Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 53: 1676-1683, 1993.
11. Sundaresan V, Ganly P, Hasleton P, Rudd R, Sinha G, Bleehen NM and Rabbitts P: p53 and chromosome-3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus. Oncogene 7: 1989-1997, 1992.
12. Sozzi G, Miozzo M, Donghi R, Pilotti S, Cariani CT, Pastorino U, Dellaporta G and Pierotti MA: Deletions of 17p and p53 mutation in preneoplastic lesions of the lung. Cancer Res 52: 6079-6082, 1992.
13. Baker SJ, Preisinger AC, Jessup JM, Paraskeva C, Markovitz S, Wilson JKV, Hamilton S and Vogelstein B: P53 gene mutations occur in combination with 17p allelic deletions as late event in colorectal tumorigenesis. Cancer Res 50: 7717-7722, 1990.
14. Murakami Y, Hayashi K, Hirohashi S and Sekiya T: Aberrationa of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 51: 5520-5525, 1991.
15. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavenee W and Vogelstein B: Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature 355: 846-847, 1992.
16. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM and Bos JL: Genetic alteration during colorectal tumor development. N Engl J Med 319: 525-532, 1988.
17. Esrig D, Spruck CH III, Nichols PW, Chaiwun B, Steven K, Groshen S, Chen SC, Skinner DG, Jones PA and Cote RJ: p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 143: 1389-1397, 1993.
18. Tanaka S, Toh Y, Adachi E, Matsumata T, Mori R and Sugimachi K: Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation. Cancer Res 53: 2884-2887, 1993.
19. Wamakulasuriya KAAS and Johnson NW: Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions. J Oral Pathol Med 21: 404-408, 1992.
20. Suckow EE, Yokoo H and Brock DR: Intraepithelial carcinoma concomitant with esophageal carcinoma. Cancer 15: 733-740, 1962.
21. Sarbia M, Porschen R, Borchard F, Horstmann O, Willers R and Gabbert HE: p53 protein expression and prognosis in squamous cell carcinoma of the esophagus. Cancer 74: 2218-2223, 1994.
22. Toh Y, Kuwano H, Sonoda K, Saeki H, Kawaguchi H, Kitamura K, Nakashima H and Sugimachi K: Correlation between reduced p21WAF1/CIP1 expression and abnormal p53 expression in esophageal carcinomas. Int J Oncol 11: 703-708, 1997.
23. Chaves P, Pereira AD, Pinto A, Oliveira AG, Queimado L, Glória L, Cardoso P, Mira FC and Soare J: p53 protein immunoexpression in esophageal squamous cell carcinoma and adjacent epithelium. J Surg Oncol 65: 3-9, 1997.
24. Oiwa H, Maehara Y, Ohno S, Sakaguchi Y, Ichiyoshi Y and Sugimachi K: Growth pattern and p53 overexpression in patients with early gastric cancer. Cancer 75 (Suppl.): 1454-1459, 1995.